The pen injector platform is designed to lower pharma costs, risks, and Market barriers. (Credit: Phillips-Medisize)

A disposable pen injector has been designed to facilitate faster, more efficient, and cost-effective market entry. Ideally suited for high-volume manufacturing, from the pen injector Phillips-Medisize matches user expectations and experiences with familiar disposable pen products yet is noticeably smaller than most comparable offerings in the market.

In addition to its compact form factor, this pen injector features a flexible design with customizable dosing as well as push-button colors to signal different dosing and drug requirements for multiple therapies, including diabetes, fertility, growth hormones, obesity, and osteoporosis.

The Pen Injector Platform joins Phillips-Medisize’s Aria Smart Autoinjector, which was introduced in May 2021 to meet rising demands for innovation, differentiation and sustainability in the digital drug-delivery device market.